Alkixen 250 mg (Crizotinib) Capsules

Alkixen (Crizotinib) 250 mg is a targeted anticancer medicine used to treat specific types of non-small cell lung cancer (NSCLC) associated with ALK or ROS1 gene rearrangements. It works by blocking abnormal signaling pathways that promote cancer cell growth and spread.

Therapeutic Effects:

• Helps slow the progression of ALK-positive NSCLC
• Effective in ROS1-positive advanced lung cancer
• Inhibits cancer cell growth and multiplication
• May help reduce tumor size in eligible patients
• Supports disease control in metastatic lung cancer
• Provides targeted treatment with precision oncology benefits
• Helps delay cancer progression and improve treatment outcomes

Active Ingredient:

• Crizotinib BP 250 mg

Composition:
Each hard capsule contains Crizotinib BP equivalent to 250 mg Crizotinib.

Pharmacological Category:

• Tyrosine Kinase Inhibitor (TKI)
• ALK Inhibitor
• ROS1 Inhibitor
• Targeted Anticancer Agent

Active Ingredient:

• Crizotinib BP 250 mg

Composition:
Each hard capsule contains Crizotinib BP equivalent to 250 mg Crizotinib.

Pharmacological Category:

• Tyrosine Kinase Inhibitor (TKI)
• ALK Inhibitor
• ROS1 Inhibitor
• Targeted Anticancer Agent

Dosage & Administration

Recommended Adult Dose:

• One 250 mg capsule taken orally twice daily, or as directed by a qualified oncologist.

Administration Instructions:

• Swallow the capsule whole with water.
• Do not crush, chew, or open the capsule.
• Can be taken with or without food.
• Take doses at approximately the same times each day.
• Continue treatment according to the physician's recommendation.

Missed Dose:

• If a dose is missed, take it as soon as remembered unless the next scheduled dose is due within 6 hours.
• Do not take two doses at the same time to make up for a missed dose.

Important Notes:

• Dose adjustments may be necessary based on tolerability, side effects, liver function, kidney function, or other medical considerations.
• Regular monitoring may be required during treatment.
• Always follow the prescribing oncologist's instructions for optimal therapeutic benefit.